Evidence map›Paper›PMID 34506568›Full record

ArticlePloS one2021

Increased levels of circulating LPS during Tuberculosis prevails in patients with advanced pulmonary involvement.

Georgina Gallucci, Natalia Santucci, Ariana Díaz, Bettina Bongiovanni, Diego Bértola, Walter Gardeñez, Mauricio Rassetto, María Luisa Bay, Oscar Bottasso, Luciano D'Attilio

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Review
  4. Article
  5. Review
  6. Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Georgina GallucciInstituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Santa Fe, Argentina.
Natalia SantucciInstituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Santa Fe, Argentina.ORCID 0000-0002-2440-2296
Ariana DíazInstituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Santa Fe, Argentina.
Bettina BongiovanniInstituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Santa Fe, Argentina.
Diego BértolaServicio de Clínica Médica, Hospital Provincial del Centenario, Rosario, Santa Fe, Argentina.
Walter GardeñezServicio de Neumología, Hospital Provincial del Centenario, Rosario, Santa Fe, Argentina.
Mauricio RassettoCentro de investigación y biotecnología (CIBIO) Wiener Lab, Rosario, Argentina.
María Luisa BayInstituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Santa Fe, Argentina.
Oscar BottassoInstituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Santa Fe, Argentina.
Luciano D'AttilioInstituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Santa Fe, Argentina.ORCID 0000-0002-4676-8555
Consejo Nacional de Investigaciones Científicas y Técnicas · ARHospital Provincial de Rosario · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our earlier studies in tuberculosis (TB) patients indicate that in those where the process evolves to a larger pulmonary involvement, the immune endocrine response may promote an unfavorable environment. Chronic infectious diseases, and their persistent proinflammatory response, may affect mucosal barriers integrity favoring the translocation of gastrointestinal bacteria, leading to an increase of circulating lipopolysaccharides (LPS). Consequently, we quantified LPS levels in TB patients, with different degrees of pulmonary involvement, and controls (Co) and analyzed the possible relationship between LPS and inflammatory mediators i.e., C reactive protein (CRP), interleukin 6 (IL-6) and Interferon-gamma (IFN-γ), Erythrocyte Sedimentation Rate (ESR), steroid hormones (Cortisol and Dehydroepiandrosterone, DHEA), and inflammatory transcripts from peripheral blood mononuclear cells (IL-1β, IL-6, IFN-γ). LPS was assessed by the Limulus amoebocyte lysate assay and the ELISA technique was used to quantify hormones and cytokines in the plasma samples. Cytokine transcripts from PBMC were evaluated by qRT-PCR. Non-parametric tests were used. LPS levels were increased in TB patients, as did levels of CRP, IL-6, IFN-γ, cortisol and ESR. Severe patients had the highest amounts of circulating LPS; with moderate and severe cases showing much higher levels of CRP, ESR, IL-6, IFN-γ and cortisol/DHEA ratio, as an endocrine imbalance. Only in PBMC from severe cases was mRNA for IL-1β increased. Correlation analysis showed that levels of LPS from severe patients were positively associated with IL-6 and IFN-γ plasma concentrations and with IL-1β transcripts, while IL-6 had a positive correlation with the cortisol/DHEA ratio. The higher levels of circulating LPS during progressive TB may emerge as a contributing factor for the persistence of the greater immune endocrine imbalance distinctive of advanced disease, which might suggest a vicious cycle among LPS, inflammation and endocrine imbalance.

Indexed as

AdolescentAdultAgedC-Reactive ProteinHumansInterferon-gammaInterleukin-1betaInterleukin-6Leukocytes, MononuclearLipopolysaccharidesMiddle AgedMycobacterium tuberculosisTuberculosisYoung AdultC-Reactive ProteinInterferon-gammaInterleukin-1betaInterleukin-6Lipopolysaccharides

Identifiers

PMID34506568
PMCPMC8432878
OpenAlexW3196617692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.